The lung may play a role in the pathogenesis of rheumatoid arthritis

International Journal of Clinical Rheumatology

Volumn 9, Issue 3, 2014, Pages 295-309

  Demoruelle, M Kristen ^a,b   Solomon, Joshua J ^b   Fischer, Aryeh ^a,b   Deane, Kevin D ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

lung disease; pathogenesis; preclinical autoimmunity; rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ASTHMA; AUTOIMMUNITY; BRONCHIECTASIS; BRONCHITIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; EMPHYSEMA; ENVIRONMENTAL FACTOR; HUMAN; LUNG DISEASE; MEDICAL SOCIETY; NUTRITIONAL ASSESSMENT; PATHOGENESIS; PHYSICAL EXAMINATION; PLEURA EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT MUCOSA; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR;

EID: 84905435399     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.14.23     Document Type: Review

References (109)

1. Helmick CG, Felson DT, Lawrence RC et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 58(1), 15-25 (2007).
2. Klareskog L, Padyukov L, Ronnelid J, Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr. Opin. Immunol. 18(6), 650-655 (2006).
3. Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54(1), 38-46 (2006).
4. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31(3), 315-324 (1988).
5. Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569-2581 (2010).
6. Demoruelle MK, Parish MC, Derber LA et al. Performance of anti-cyclic citrullinated peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease. Arthritis Rheum. 65(9), 2243-2252 (2013).
7. Rantapaa-Dahlqvist S, De Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48(10), 2741-2749 (2003).
8. Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir. Med. 106(11), 1591-1599 (2012).
9. Giles JT, Danoff SK, Sokolove J et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann. Rheum. Dis. PMC3883892 (2013) (Epub ahead of print).
10. Harlow L, Rosas IO, Gochuico BR et al. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum. 65(4), 869-879 (2013).
11. Svard A, Kastbom A, Soderlin MK, Reckner-Olsson A, Skogh T. A comparison between IgG-and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. J. Rheumatol. 38(7), 1265-1272 (2011).
12. Shi J, Knevel R, Suwannalai P et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl Acad. Sci. USA 108(42), 17372-17377 (2011).
13. Harris ML, Darrah E, Lam GK et al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum. 58(7), 1958-1967 (2008).
14. Brink M, Hansson M, Mathsson L et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 65(4), 899-910 (2013).
15. Nielen MM, Van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50(2), 380-386 (2004).
16. Majka DS, Deane KD, Parrish LA et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann. Rheum. Dis. 67(6), 801-807 (2008).
17. Sokolove J, Bromberg R, Deane KD et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7(5), e35296 (2012).
18. Kolfenbach JR, Deane KD, Derber LA et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum. 61(12), 1735-1742 (2009).
19. Van De Stadt LA, Bos WH, Meursinge Reynders M et al. The value of ultrasonography in predicting arthritis in autoantibody positive arthralgia patients: a prospective cohort study. Arthritis Res. Ther. 12(3), R98 (2010).
20. Van De Sande MG, De Hair MJ, Van Der Leij C et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann. Rheum. Dis. 70(5), 772-777 (2011).
21. Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun. Rev. 11(2), 123-131 (2011).
22. Turesson C. Extra-articular rheumatoid arthritis. Curr. Opin. Rheumatol. 25(3), 360-366 (2013).
23. Brown KK. Rheumatoid lung disease. Proc. Am. Thorac. Soc. 4(5), 443-448 (2007).
24. Mason R, Broaddus V, Martin T, King Jr T, Schraufnagel D, Murray J, Nadel J. Murray and Nadels Textbook of Respiratory Medicine (5th Edition). Elsevier Health Sciences, Amsterdam, The Netherlands (2010).
25. Abe K, Mitsuka T, Yamaoka A et al. Sudden glottic stenosis caused by cricoarytenoid joint involvement due to rheumatoid arthritis. Intern. Med. 52(21), 2469-2472 (2013).
26. Demoruelle MK, Weisman MH, Simonian PL et al. Brief report: airways abnormalities and rheumatoid arthritisrelated autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum. 64(6), 1756-1761 (2012).
27. Reynisdottir G, Karimi R, Joshua V et al. Structural lung changes and local anti-citrulline immunity are early features of anti citrullinated-proteins antibodies positive rheumatoid arthritis. Arthritis Rheum. 66, 31-39 (2013).
28. Yuksekkaya R, Celikyay F, Yilmaz A et al. Pulmonary involvement in rheumatoid arthritis: multidetector computed tomography findings. Acta Radiol. 54(10), 1138-1149 (2013).
29. Wilsher M, Voight L, Milne D et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir. Med. 106(10), 1441-1446 (2012).
30. Gabbay E, Tarala R, Will R et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am. J. Respir. Crit. Care Med. 156(2 Pt 1), 528-535 (1997).
31. Metafratzi ZM, Georgiadis AN, Ioannidou CV et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand. J. Rheumatol. 36(5), 338-344 (2007).
32. Chen J, Shi Y, Wang X, Huang H, Ascherman D. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin. Dev. Immunol. 2013, 406927 (2013).
33. Gupta S, Siddiqui S, Haldar P et al. Qualitative analysis of high-resolution CT scans in severe asthma. Chest 136(6), 1521-1528 (2009).
34. McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br. J. Rheumatol. 33(2), 118-122 (1994).
35. Fischer A, Solomon JJ, Du Bois RM et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir. Med. 106(7), 1040-1047 (2012).
36. Cavagna L, Monti S, Grosso V et al. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis. Biomed. Res. Int. 2013, 759760 (2013).
37. Gochuico BR, Avila NA, Chow CK et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch. Intern. Med. 168(2), 159-166 (2008).
38. Reynolds H. Respiratory Structure and Function (22nd Edition). Saunders, PA, USA (2004).
39. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157(5 Pt 1), 1666-1680 (1998).
40. Seibold MA, Smith RW, Urbanek C et al. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS ONE 8(3), e58658 (2013).
41. Yang IV, Coldren CD, Leach SM et al. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax 68(12), 1114-1121 (2013).
42. Aubart F, Crestani B, Nicaise-Roland P et al. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J. Rheumatol. 38(6), 979-982 (2011).
43. Chandra PE, Sokolove J, Hipp BG et al. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res. Ther. 13(3), R102 (2011).
44. Gizinski AM, Mascolo M, Loucks JL et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin. Rheumatol. 28(5), 611-613 (2009).
45. Kokkonen H, Mullazehi M, Berglin E et al. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res. Ther. 13(1), R13 (2011).
46. Arlestig L, Mullazehi M, Kokkonen H, Rocklov J, Ronnelid J, Dahlqvist SR. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann. Rheum. Dis. 71(6), 825-829 (2012).
47. Barra L, Scinocca M, Saunders S et al. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum. 65(6), 1439-1447 (2013).
48. Demoruelle MK, Deane KD, Holers VM. When and where does inflammation begin in rheumatoid arthritis? Curr. Opin. Rheumatol. 26(1), 64-71 (2014).
49. Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Immunobiology (5th Edition). Garland Science, NY, USA (2001).
50. Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13(11), 1006-1012 (1995).
51. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116(12), 3183-3194 (2006).
52. Kolarz G, Scherak O, Popp W et al. Bronchoalveolar lavage in rheumatoid arthritis. Br. J. Rheumatol. 32(7), 556-561 (1993).
53. Willis VC, Demoruelle MK, Derber LA et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 65(10), 2545-2554 (2013).
54. Schiotz PO, Egeskjold EM, Hoiby N, Permin H. Autoantibodies in serum and sputum from patients with cystic fibrosis. Acta Pathol. Microbiol. Scand. C 87(5), 319-324 (1979).
55. Newkirk MM, Mitchell S, Procino M et al. Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur. J. Immunol. 42(4), 1051-1061 (2012).
56. Ruiz-Esquide V, Gomara MJ, Peinado VI et al. Anticitrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin. Rheumatol. 31(7), 1047-1050 (2012).
57. Makrygiannakis D, Hermansson M, Ulfgren AK et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum. Dis. 67(10), 1488-1492 (2008).
58. Heliovaara M, Aho K, Knekt P, Aromaa A, Maatela J, Reunanen A. Rheumatoid factor, chronic arthritis and mortality. Ann. Rheum. Dis. 54(10), 811-814 (1995).
59. Tuomi T, Heliovaara M, Palosuo T, Aho K. Smoking, lung function, and rheumatoid factors. Ann. Rheum. Dis. 49(10), 753-756 (1990).
60. Van Venrooij WJ, Pruijn GJ. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2(4), 249-251 (2000).
61. Baka Z, Barta P, Losonczy G et al. Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production. Int. Immunol. 23(6), 405-414 (2011).
62. Verpoort KN, Cheung K, Ioan-Facsinay A et al. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum. 56(12), 3949-3952 (2007).
63. Klareskog L, Gregersen PK, Huizinga TW. Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann. Rheum. Dis. 69(12), 2062-2066 (2010).
64. Bos WH, Wolbink GJ, Boers M et al. Arthritis development in patients with arthralgia is strongly associated with anticitrullinated protein antibody status: a prospective cohort study. Ann. Rheum. Dis. 69(3), 490-494 (2010).
65. Haj Hensvold A, Magnusson PK, Joshua V et al. Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Ann. Rheum. Dis. doi:10.1136/ annrheumdis-2013-203947 (2013) (Epub ahead of print).
66. Ramirez AS, Rosas A, Hernandez-Beriain JA et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study. Rheumatology (Oxford) 44(7), 912-914 (2005).
67. Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford) 44(11), 1433-1441 (2005).
68. Rashid T, Ebringer A. Rheumatoid arthritis is linked to Proteus -the evidence. Clin. Rheumatol. 26(7), 1036-1043 (2007).
69. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4(Suppl. 3), S265-S272 (2002).
70. Wegner N, Lundberg K, Kinloch A et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233(1), 34-54 (2010).
71. Scher JU, Ubeda C, Equinda M et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 4(10), 3083-3094 (2012).
72. Scher JU, Sczesnak A, Longman RS et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2, e01202 (2013).
73. Charlson ES, Bittinger K, Haas AR et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184(8), 957-963 (2011).
74. Lozupone C, Cota-Gomez A, Palmer BE et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am. J. Respir. Crit. Care Med. 187(10), 1110-1117 (2013).
75. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am. J. Respir. Crit. Care Med. 187(12), 1382-1387 (2013).
76. Morris A, Beck JM, Schloss PD et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 187(10), 1067-1075 (2013).
77. Erb-Downward JR, Thompson DL, Han MK et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS ONE 6(2), e16384 (2011).
78. Goleva E, Jackson LP, Harris JK et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am. J. Respir. Crit. Care Med. 188(10), 1193-1201 (2013).
79. Dimmitt RA, Staley EM, Chuang G, Tanner SM, Soltau TD, Lorenz RG. Role of postnatal acquisition of the intestinal microbiome in the early development of immune function. J. Pediatr. Gastroenterol. Nutr. 51(3), 262-273 (2010).
80. Stebbings SM, Taylor C, Tannock GW, Baird MA, Highton J. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin production. J. Rheumatol. 36(4), 797-800 (2009).
81. Proal AD, Albert PJ, Marshall TG. The human microbiome and autoimmunity. Curr. Opin. Rhumatol. 25(2), 234-240 (2013).
82. Yeoh N, Burton JP, Suppiah P, Reid G, Stebbings S. The role of the microbiome in rheumatic diseases. Curr. Rheumatol. Rep. 15(3), 314 (2013).
83. Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118(1), 205-216 (2008).
84. Wu HJ, Ivanov, Ii, Darce J et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper cells. Immunity 32(6), 815-827 (2010).
85. Horai R, Saijo S, Tanioka H et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191(2), 313-320 (2000).
86. Lundberg K, Kinloch A, Fisher BA et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58(10), 3009-3019 (2008).
87. Wegner N, Wait R, Sroka A et al. Peptidylarginine deiminase from porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62(9), 2662-2672 (2010).
88. Foo SY, Phipps S. Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunol. 3(6), 537-544 (2010).
89. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6(3), 205-217 (2006).
90. Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat. Rev. Rheumatol. 10(4), 212-228 (2014).
91. Kuhn KA, Kulik L, Tomooka B et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116(4), 961-973 (2006).
92. Harre U, Georgess D, Bang H et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122(5), 1791-1802 (2012).
93. Sokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum. 63(1), 53-62 (2011).
94. Zhao X, Okeke NL, Sharpe O et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res. Ther. 10(4), R94 (2008).
95. Van De Stadt LA, Van Der Horst AR, De Koning MH et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann. Rheum. Dis. 70(1), 128-133 (2011).
96. Mikuls TR, ODell JR, Stoner JA et al. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis Rheum. 50(12), 3776-3782 (2004).
97. Nguyen CQ, Ogunniyi AO, Karabiyik A, Love JC. Singlecell analysis reveals isotype-specific autoreactive B cell repertoires in Sjogrens syndrome. PLoS ONE 8(3), e58127 (2013).
98. Snir O, Backlund J, Bostrom J et al. Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritis. Arthritis Rheum. 64(8), 2482-2488 (2012).
99. Dye JR, Ullal AJ, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Immunol. 78(2), 140-148 (2013).
100. Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjogren syndrome. Clin. Chest Med. 31(3), 489-500 (2010).
101. Fischer A, West SG, Swigris JJ, Brown KK, Du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 138(2), 251-256 (2010).
102. Zach JA, Newell JD Jr, Schroeder J et al. Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest. Radiol. 47(10), 596-602 (2012).
103. Kato A, Hulse KE, Tan BK, Schleimer RP. B-lymphocyte lineage cells and the respiratory system. J. Allergy Clin. Immunol. 131(4), 933-957; quiz 958 (2013).
104. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Ann. Rev. Immunol. 29, 273-293 (2011).
105. Huo Z, Bissett SL, Giemza R, Beddows S, Oeser C, Lewis DJ. Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. PLoS ONE 7(3), e33736 (2012).
106. Agarwal V, Misra R, Aggarwal A. Immune complexes contain immunoglobulin A rheumatoid factor in serum and synovial fluid of patients with polyarticular juvenile rheumatoid arthritis. Rheumatology 41(4), 466-467 (2002).
107. Keith RC, Sokolove J, Edelman BL et al. Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice. Arthritis Rheum. 65(6), 1487-1493 (2013).
108. Saag KG, Kolluri S, Koehnke RK et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 39(10), 1711-1719 (1996).
109. Keith RC, Powers JL, Redente EF et al. A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice. Exp. Lung Res. 38(2), 55-66 (2012).